Prevention of estrogen-induced uterine hyperemia by alpha-adrenergic receptor-blocking agents.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002369:Castration; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D006940:Hyperemia / Q000139:chemically induced / Q000503:physiopathology*; D009638:Norepinephrine / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism; D051381:Rats; D014599:Uterus / Q000098:blood supply / Q000187:drug effects / Q000503:physiopathology*
D000317:Adrenergic alpha-Antagonists; D011453:Prostaglandins; D004958:Estradiol; D009638:Norepinephrine